2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC405
  



  

  
Submitter : 
  

  
Dr. Hui Park
  

  
Date & Time: 
  

  
01/26/2006 06:01:48
  



  

  
Organization : 
  

  
Dr. Hui Park
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 The lack of sale in synthetic hormone therapy cannot be attribute to compounding bio-identical hormones.  It is my opinion that lack of sales in synthetic hormones is related to public education that was provided by scientific resarch.  There have been some correlation with brast cancer and pelvic cancer secondary to synthetic hormone therapy, according to some medical publications.  It is my opinion that bio-identical hormones may be ultilized better in the body better and has higher efficacy.